Furthermore, patients with a high-grade, but low-PSA prostate cancer usually have poor prognosis and poorly differentiated tumors, thereby leading to low sensitivity to traditional ADT (11), and making RP a better choice of treatment. Here, KLK3 is linked to Familial prostate cancer.